alanylglutamine has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efremov, SM; Karaskov, AM; Lomivorotov, VN; Lomivorotov, VV; Ponomarev, DN; Shmirev, VA | 1 |
| Ferrera, R; Michel, P; Ovize, M | 1 |
1 trial(s) available for alanylglutamine and Myocardial Ischemia
| Article | Year |
|---|---|
Glutamine is cardioprotective in patients with ischemic heart disease following cardiopulmonary bypass.
Topics: Cardiopulmonary Bypass; Dipeptides; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Placebos; Statistics, Nonparametric; Treatment Outcome; Troponin I | 2011 |
1 other study(ies) available for alanylglutamine and Myocardial Ischemia
| Article | Year |
|---|---|
Paradoxical toxicity of cardioplegic compounds on ischemic cardiomyocyte using optimal design strategy.
Topics: Animals; Calcium Chloride; Cardioplegic Solutions; Cell Survival; Cryopreservation; Dipeptides; Ethanol; Glutathione; Heart; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Organ Preservation Solutions; Polyethylene Glycols; Pyruvates; Research Design; Swine | 2005 |